Prasad Adusumilli

Prasad Adusumilli, MD, is Vice Chair of Translational Research and Deputy Chief of Thoracic Surgery at Memorial Sloan Kettering Cancer Center, New York. Internationally recognized for his expertise in lung cancer and mesothelioma, he performs complex and minimally invasive surgeries, and is a leader in robotic bronchoscopy for advanced, image-guided biopsies.

Dr. Adusumilli directs a cancer immunology laboratory focused on developing and translating new immunotherapies. Supported by NIH and Department of Defense grants, his team has analyzed samples from over 12,000 patients, advancing understanding of immune responses and resistance in thoracic cancers. His research pioneered insights into the role of immune cell infiltration, laying the foundation for immune modulation and novel therapies.

His group has developed solid tumor models and led clinical trials testing biological therapies, including chimeric antigen receptor (CAR) T cells, which have proven safe and effective for advanced cancers. Dr. Adusumilli’s work has informed combination immunotherapy strategies and contributed to international clinical guidelines.

He has mentored more than 150 scientists and physicians, published over 320 papers, and received over 100 research awards. Dr. Adusumilli is an elected member of the Fleischner Society, the American Society of Clinical Investigation, and the American Association for Thoracic Surgery.